FDA Warning Indicates Scrutiny Of Regenerative Health Cos.
On May 21, the Center for Biologics Evaluation and Research, or CBER, at the U.S. Food and Drug Administration published a warning letter issued to Akan Biosciences Inc. for unresolved inspection...To view the full article, register now.
Already a subscriber? Click here to view full article